These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

874 related articles for article (PubMed ID: 25483537)

  • 1. Surveillance and vaccination coverage of measles and rubella in Northern Italy.
    Amendola A; Bubba L; Piralla A; Binda S; Zanetti A; Pariani E; Ranghiero A; Premoli M; Pellegrinelli L; Coppola L; Gramegna M; Baldanti F; Zanetti A
    Hum Vaccin Immunother; 2015; 11(1):206-13. PubMed ID: 25483537
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterisation of measles after the introduction of the combined measles-mumps-rubella (MMR) vaccine in 2004 with focus on the laboratory data, 2016 to 2019 outbreak, Romania.
    Lazar M; Stănescu A; Penedos AR; Pistol A
    Euro Surveill; 2019 Jul; 24(29):. PubMed ID: 31339098
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An epidemiological assessment towards elimination of rubella and congenital rubella syndrome in Singapore.
    Chua YX; Ang LW; Low C; James L; Cutter JL; Goh KT
    Vaccine; 2015 Jun; 33(27):3150-7. PubMed ID: 25887085
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phylogenetic and epidemiological analysis of measles outbreaks in Denmark, 2013 to 2014.
    Rasmussen LD; Fonager J; Knudsen LK; Andersen PH; Rønn J; Poulsen MW; Franck KT; Fischer TK
    Euro Surveill; 2015; 20(39):. PubMed ID: 26537105
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MMR vaccination and disease elimination: the Finnish experience.
    Davidkin I; Kontio M; Paunio M; Peltola H
    Expert Rev Vaccines; 2010 Sep; 9(9):1045-53. PubMed ID: 20822347
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Progress toward measles and rubella elimination in Egypt.
    El Sayed N; Kandeel N; Barakat I; Moussa I; Alexander JP; Naouri B; Reef SE
    J Infect Dis; 2011 Jul; 204 Suppl 1():S318-24. PubMed ID: 21666180
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ongoing measles outbreak in Romania, 2011.
    Stanescu A; Janta D; Lupulescu E; Necula G; Lazar M; Molnar G; Pistol A
    Euro Surveill; 2011 Aug; 16(31):. PubMed ID: 21871218
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Towards measles elimination in Italy: Virological surveillance and genotypes trend (2013-2015).
    Magurano F; Baggieri M; Filia A; Del Manso M; Lazzarotto T; Amendola A; D'Agaro P; Chironna M; Ansaldi F; Iannazzo S; Bucci P; Marchi A; Nicoletti L;
    Virus Res; 2017 May; 236():24-29. PubMed ID: 28522332
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Spatiotemporal distribution and determinants of measles incidence during a large outbreak, Italy, September 2016 to July 2018.
    Andrianou XD; Del Manso M; Bella A; Vescio MF; Baggieri M; Rota MC; Pezzotti P; Filia A
    Euro Surveill; 2019 Apr; 24(17):. PubMed ID: 31039836
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Economic analysis of measles elimination program in the Republic of Korea, 2001: a cost benefit analysis study.
    Bae GR; Choe YJ; Go UY; Kim YI; Lee JK
    Vaccine; 2013 May; 31(24):2661-6. PubMed ID: 23602654
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Australian vaccine preventable disease epidemiological review series: rubella 2008-2012.
    Chan J; Dey A; Wang H; Martin N; Beard F
    Commun Dis Intell Q Rep; 2015 Mar; 39(1):E19-26. PubMed ID: 26063094
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epidemiology of measles, mumps and rubella in Italy.
    Gabutti G; Rota MC; Salmaso S; Bruzzone BM; Bella A; Crovari P;
    Epidemiol Infect; 2002 Dec; 129(3):543-50. PubMed ID: 12558337
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ongoing measles and rubella transmission in Georgia, 2004-05: implications for the national and regional elimination efforts.
    Doshi S; Khetsuriani N; Zakhashvili K; Baidoshvili L; Imnadze P; Uzicanin A
    Int J Epidemiol; 2009 Feb; 38(1):182-91. PubMed ID: 19074954
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The active offering of measles, rubella and mumps vaccine in new mothers: the experience of health facilities in one of the Local Health Unit of Rome, Lazio, Italy].
    Santoro V; Pettinicchio V; Lancia A; Vazzoler C; De Luca F; Franco E
    Ig Sanita Pubbl; 2016; 72(6):589-597. PubMed ID: 28214912
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Towards elimination of measles and rubella in Italy: Progress and challenges.
    Adamo G; Baccolini V; Massimi A; Barbato D; Cocchiara R; Di Paolo C; Mele A; Cianfanelli S; Angelozzi A; Castellani F; Salerno C; Isonne C; Bella A; Filia A; Del Manso M; Baggieri M; Nicoletti L; Magurano F; Iannazzo S; Marzuillo C; Villari P
    PLoS One; 2019; 14(12):e0226513. PubMed ID: 31841530
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular epidemiology of measles virus in Taiwan in 2010-2011: the common genotype changed from H1 to D9 and the first appearance of D4.
    Cheng WY; Tung HP; Wang HC; Lee LL; Wu HS; Liu MT
    J Med Virol; 2013 Jun; 85(6):1095-9. PubMed ID: 23588738
    [TBL] [Abstract][Full Text] [Related]  

  • 17. EpiReview: Measles in NSW, 2002-2011.
    Rosewell A; Reinten-Reynolds T; Spokes PJ
    N S W Public Health Bull; 2012 Dec; 23(9-10):201-7. PubMed ID: 23442997
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Surveillance Plan on Recent Outbreak of Measles and Rubella in Catalonia, Spain].
    Jané M; Torner N; Vidal MJ
    Rev Esp Salud Publica; 2015; 89(4):397-406. PubMed ID: 26580795
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epidemiologic and laboratory surveillance of the measles outbreak in the Federation of Bosnia and Herzegovina, February 2014-April 2015.
    Salimović-Bešić I; Šeremet M; Hübschen JM; Hukić M; Tihić N; Ahmetagić S; Delibegović Z; Pilav A; Mulaomerović M; Ravlija J; Muller CP; Dedeić-Ljubović A
    Clin Microbiol Infect; 2016 Jun; 22(6):563.e1-7. PubMed ID: 26928202
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The elimination of indigenous measles, mumps, and rubella from Finland by a 12-year, two-dose vaccination program.
    Peltola H; Heinonen OP; Valle M; Paunio M; Virtanen M; Karanko V; Cantell K
    N Engl J Med; 1994 Nov; 331(21):1397-402. PubMed ID: 7969278
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 44.